Tombstone Exploration (TMBXF) 20-F/A 2 Aug 17 2015 FY Annual report (foreign) (amended) Financial data

Document and Entity Information

Document and Entity Information - shares	12 Months Ended
	Dec. 31, 2015	Sep. 08, 2016
Document And Entity Information
Entity Registrant Name	TOMBSTONE EXPLORATION CORP
Entity Central Index Key	1,072,772
Document Type	20-F/A
Document Period End Date	Dec. 31, 2015
Amendment Flag	true
Current Fiscal Year End Date	--12-31
Is Entity a Well-known Seasoned Issuer?	No
Is Entity a Voluntary Filer?	No
Is Entity's Reporting Status Current?	Yes
Entity Filer Category	Non-accelerated Filer
Entity Common Stock, Shares Outstanding		289,170,251
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2,015
Amendment Description	EXPLANATORY NOTE This Amendment No. 3 on Form 20-F/A amends the Company’s Annual Report on Form 20-F for the year ended December 31, 2015, as filed with the Securities and Exchange Commission (the “SEC”) on September 9, 2016 (the “Original Filing”). The purpose of this Amendment No. 3 on Form 20-F/A is to respond to certain comments received from the Staff of the SEC. For convenience and ease of reference, the Company is filing this Form 20-F/A in its entirety with all applicable changes and unless otherwise stated, all information contained in this amendment is as of the filing date of the Original Filing. Except as stated herein, this Form 20-F/A does not reflect events or transactions occurring after such filing date or modify or update those disclosures in the original Form 20-F that may have been affected by events or transactions occurring subsequent to such filing date.

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Current liabilities
Derivative liabilities	$ 292,320	$ 237,061
Stockholders' Deficit
Accumulated deficit	(24,899,638)
Consolidated Balance Sheets
Current assets
Cash	164,808
Amounts receivable	302
Total current assets	165,110
Property and equipment, net of accumulated depreciation	2,262
Deferred financing costs	1,527
Total assets	168,899
Current liabilities
Accounts payable	40,410
Accrued liabilities	4,455
Due to related parties	4,408
Convertible debenture, net of unamortized discount of $65,742 and $65,444, respectively	97,092
Derivative liabilities	292,320
Total liabilities	438,685
Stockholders' Deficit
Common stock: Authorized: unlimited common shares, with no par value, issued and outstanding: 251,285,912 and 211,841,789 common shares, respectively	19,474,010
Common stock subscribed	190,000
Additional paid-in capital	4,965,842
Accumulated deficit	(24,899,638)
Total stockholders' deficit	(269,786)
Total liabilities and stockholders' deficit	$ 168,899
As restated - Note 12
Current assets
Cash		3,363
Amounts receivable
Total current assets		3,363
Property and equipment, net of accumulated depreciation		5,885
Deferred financing costs		4,441
Total assets		13,689
Current liabilities
Accounts payable		5,541
Accrued liabilities		5,107
Due to related parties		3,950
Convertible debenture, net of unamortized discount of $65,742 and $65,444, respectively		53,055
Derivative liabilities		237,061
Total liabilities		304,714
Stockholders' Deficit
Common stock: Authorized: unlimited common shares, with no par value, issued and outstanding: 251,285,912 and 211,841,789 common shares, respectively		18,875,828
Common stock subscribed		50,000
Additional paid-in capital		4,965,842
Accumulated deficit		(24,182,695)
Total stockholders' deficit		(291,025)
Total liabilities and stockholders' deficit		$ 13,689

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Consolidated Balance Sheets
Unamortized discount of convertible debenture	$ 65,742
Common stock, shares issued	251,285,912
Common stock, shares outstanding	251,285,912
As restated - Note 12
Unamortized discount of convertible debenture		$ 65,444
Common stock, shares issued		211,841,789
Common stock, shares outstanding		211,841,789

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Operating expenses
Management and directors fees	$ 135,000	$ 120,000	$ 120,000
Consolidated Statements of Operations
Operating expenses
Consulting services	70,849
General and administrative	53,686
Management and directors fees	135,000
Mineral properties	10,987
Professional fees	77,495
Total operating expenses	348,017
Operating loss	(348,017)
Other income (expense)
Gain on forgiveness of debt
Loss on change in fair value of derivative liabilities	(202,193)
Accretion and interest expense	(166,733)
Total other income (expense)	(368,926)
Net loss	$ (716,943)
Net loss per share - basic and diluted	$ 0
Weighted average shares outstanding	241,823,423
As restated - Note 12
Operating expenses
Consulting services		197,131	22,000
General and administrative		51,204	48,269
Management and directors fees		120,000	120,000
Mineral properties		12,129	4,445
Professional fees		102,027	32,609
Total operating expenses		482,491	227,323
Operating loss		(482,491)	(227,323)
Other income (expense)
Gain on forgiveness of debt		65,000
Loss on change in fair value of derivative liabilities		(82,138)	(168,930)
Accretion and interest expense		(309,081)	(127,531)
Total other income (expense)		(326,219)	(296,461)
Net loss		$ (808,710)	$ (523,784)
Net loss per share - basic and diluted		$ 0	$ 0
Weighted average shares outstanding		171,960,998	111,722,313

Consolidated Statement of Stock

Consolidated Statement of Stockholders' Deficit - USD ($)	Common Shares	Additional Paid-In Capital	Common Stock Subscribed	Accumulated Deficit	Total
Beginning balance, shares at Dec. 31, 2012	103,660,905
Beginning balance, amount at Dec. 31, 2012	$ 17,646,580	$ 4,965,842	$ 61,745	$ (22,850,201)	$ (176,304)
Issuance of common shares for cash, shares	6,500,000
Issuance of common shares for cash, amount	$ 65,000				65,000
Issuance of common shares for settlement of related party payable, shares	5,200,000
Issuance of common shares for settlement of related party payable, amount	$ 52,000				52,000
Issuance of common shares on conversion of debt, shares	6,378,209
Issuance of common shares on conversion of debt, amount	$ 228,727				228,727
Common stock subscribed, shares	675,000
Common stock subscribed, amount	$ 11,475		11,475
Net loss for the year				(523,784)	(523,784)
Ending balance, shares at Dec. 31, 2013	122,414,114
Ending balance, amount at Dec. 31, 2013	$ 18,003,782	4,965,842	50,000	(23,373,985)	(354,361)
Issuance of common shares for cash, shares	69,000,000
Issuance of common shares for cash, amount	$ 100,000				100,000
Issuance of common shares for services, shares	2,000,000
Issuance of common shares for services, amount	$ 88,190				88,190
Issuance of common shares on conversion of debt, shares	18,427,675
Issuance of common shares on conversion of debt, amount	$ 683,856				683,856
Net loss for the year				(808,710)	(808,710)
Ending balance, shares at Dec. 31, 2014	211,841,789
Ending balance, amount at Dec. 31, 2014	$ 18,875,828	4,965,842	50,000	(24,182,695)	(291,025)
Issuance of common shares for cash, shares	15,000,000
Issuance of common shares for cash, amount	$ 150,000				150,000
Share issuance costs			(10,000)		(10,000)
Issuance of common shares for services, shares	500,000
Issuance of common shares for services, amount	$ 5,900				5,900
Issuance of common shares on conversion of debt, shares	23,944,123
Issuance of common shares on conversion of debt, amount	$ 442,282				442,282
Common stock subscribed, amount			150,000		150,000
Net loss for the year				(716,943)	(716,943)
Ending balance, shares at Dec. 31, 2015	251,285,912
Ending balance, amount at Dec. 31, 2015	$ 19,474,010	$ 4,965,842	$ 190,000	$ (24,899,638)	$ (269,786)

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Conslidated Statements of Cash Flows
Operating Activities
Net loss	$ (716,943)
Adjustments to reconcile net loss to net cash used in operating activities:
Accretion expense	155,361
Common stock issued for services	5,900
Depreciation expense	3,623
Gain on forgiveness of debt
Loss on change in fair value of derivative liabilities	202,193
Changes in operating assets and liabilities:
Amounts receivable	(302)
Deferred financing costs	1,464
Accounts payable and accrued liabilities	38,029
Net cash used in operating activities	(310,675)
Financing Activities
Proceeds from issuance of common shares and share subscriptions	300,000
Proceeds from issuance of convertible debt	186,000
Repayments of convertible debt	(13,780)
Proceeds from related parties
Repayments to related parties	(100)
Net cash provided by financing activities	472,120
Change in cash	161,445
Cash, beginning of year	3,363	$ 43,560	$ 578
Cash, end of year	164,808	3,363	43,560
Non-cash Investing and Financing Activities
Common stock issued to settle debt and accrued interest	442,282
Common stock issued to settle related party debt
Supplemental Disclosures
Interest paid
Income tax paid
As restated - Note 12
Operating Activities
Net loss		(808,710)	(523,784)
Adjustments to reconcile net loss to net cash used in operating activities:
Accretion expense		287,639	127,531
Common stock issued for services		88,190
Depreciation expense		4,029	5,221
Gain on forgiveness of debt		(65,000)
Loss on change in fair value of derivative liabilities		82,138	168,930
Changes in operating assets and liabilities:
Amounts receivable
Deferred financing costs		27,536	(7,078)
Accounts payable and accrued liabilities		5,685	(4,926)
Net cash used in operating activities		(378,493)	(234,106)
Financing Activities
Proceeds from issuance of common shares and share subscriptions		100,000	65,000
Proceeds from issuance of convertible debt		245,000	232,500
Repayments of convertible debt
Proceeds from related parties			15,500
Repayments to related parties		(6,704)	(35,912)
Net cash provided by financing activities		338,296	277,088
Change in cash		(40,197)	42,982
Non-cash Investing and Financing Activities
Common stock issued to settle debt and accrued interest		683,856	125,142
Common stock issued to settle related party debt			52,000
Supplemental Disclosures
Interest paid
Income tax paid

Nature of Operations and Contin

Nature of Operations and Continuance of Business	12 Months Ended
	Dec. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Operations and Continuance of Business	1. Nature of Operations and Continuance of Business Tombstone Exploration Corporation (the “Company”) was incorporated under the Canada Business Corporations Act on October 30 , 1997 as 3430502 Canada Ltd. On December 4, 1997, the Company changed its name to Four Crown Foods Inc., with its principal operations focused on the food and beverage retail business. In April 2000, upon acquisition of the license rights to a domain registration, the Company discontinued its operations in the food and beverage retail industry and formally changed its name to Universal Domains Incorporated on June 5, 2000. In 2001, the Company withdrew from the domain registration business and acquired 100% of the issued and outstanding common shares of VCL Communications Corp. (“VCL”), a teleconferencing services company that targeted clients throughout North America. In November 2003, given the Company’s liabilities and the lack of profitability, the Company ceased all operations. On September 20, 2004, the Company focused its operations on the exploration, development, production, and acquisition of crude oil and natural gas properties, changing its name to Pure Capital Incorporated. On November 1, 2006, the Company commenced negotiations to acquire several mining and mineral right claims which was closed on December 4, 2006 where the Company acquired 100% of the mineral claims located in Tombstone, Arizona in exchange for $100,000 and the issuance of 8,000,000 common shares of the Company. Effectively, on February 6, 2007, the Company changed its name to Tombstone Exploration Corporation to better reflect the Company’s current business objective and strategies. These consolidated financial statements have been prepared on a going concern basis, which implies that the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The Company has generated no revenues to date and has never paid any dividends and is unlikely to pay dividends or generate significant earnings in the immediate or foreseeable future. As at December 31, 2015, the Company did not record any revenues, had a working capital deficit of $273,575 and an accumulated deficit of $24,899,638. The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholders, the ability to raise equity or debt financing, and the attainment of profitable operations from the Company's future business. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern. These consolidated financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern. The Company’s plan of action over the next twelve months is to raise capital financing to conduct exploration and drilling on its mineral property claims held in Tombstone, Arizona as well as exploring for new mineral property claims in the United States.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2015
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies a) Basis of Presentation and Principles of Consolidation These consolidated financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States, and are expressed in US dollars. The consolidated financial statements include the accounts of the Company and its subsidiary, Tombstone Mining and Exploration Corporation. All inter-company accounts and transactions have been eliminated. The Company’s fiscal year-end is December 31. b) Use of Estimates The preparation of these consolidated financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the useful life and recoverability of long lived assets, fair value of stock-based compensation, valuation of convertible debentures and derivative liabilities, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. c) Cash and Cash Equivalents The Company considers all highly liquid instruments with maturity of three months or less at the time of issuance to be cas h equivalents. As at December 31, 2015 and 2014, the Company had no cash equivalents. d) Property and Equipment Property and equipment are recorded at the lower of cost or net book value, and are amortized based on the following rates: Equipment 5 years straight-line e) Impairment of Long-Lived Assets In accordance with ASC 360, Property Plant and Equipment f) Mineral Properties Mineral property acquisition and exploration costs are expensed as incurred. When it has been determined that a mineral property can be economically developed as a result of establishing proven and probable reserves, the costs incurred to develop such property are capitalized. Such costs will be amortized using the units-of-production method over the estimated life of the probable reserve. If mineral properties are subsequently abandoned or impaired, any capitalized costs will be charged to operations. g) Stock-Based Compensation The Company records stock-based compensation in accordance with ASC 505, Equity Share-Based Payments h) Revenue Recognition The Company recognizes revenue in accordance with ASC 605, Revenue Recognition. i) Income Taxes Potential benefits of income tax losses are not recognized in the accounts until realization is more likely than not. The Company has adopted ASC 740, Accounting for Income Taxes, j) Comprehensive Loss ASC 220, Comprehensive Income, k) Derivative Liability From time to time, the Company may issue equity instruments that may contain an embedded derivative instrument which may result in a derivative liability. A derivative liability exists on the date the equity instrument is issued when there is a contingent exercise provision. The derivative liability is recorded at its fair value calculated by using an option pricing model such as a multi-nominal lattice model or Black-Scholes model. The fair value of the derivative liability is then calculated on each balance sheet date with the corresponding gains and losses recorded in the consolidated statement of operations. l) Basic and Diluted Net Income (Loss) Per Share The Company computes net income (loss) per share in accordance with ASC 260, Earning per Share m) Financial Instruments Pursuant to ASC 820, Fair Value Measurements and Disclosures Financial Instruments Level 1 Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Level 2 Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. Level 3 Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. The Company’s financial instruments consist principally of cash, accounts payable and accrued liabilities, amounts due to related parties, and convertible debentures. Pursuant to ASC 820 and 825, the fair value of our cash and cash equivalents is determined based on “Level 1” inputs, which consist of quoted prices in active markets for identical assets. We believe that the recorded values of all of our other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations. The Company’s operations are in Canada, which results in exposure to market risks from changes in foreign currency rates. The financial risk is the risk to the Company’s operations that arise from fluctuations in foreign exchange rates and the degree of volatility of these rates. Currently, the Company does not use derivative instruments to reduce its exposure to foreign currency risk. The following table presents assets and liabilities that are measured and recognized at fair value as of December 31, 2015, 2014, and 2013 on a recurring basis: December 31, 2013 Description Level 1 $ Level 2 $ Level 3 $ Total Gains and (Losses) $ Derivative liability — (286,669 ) — (168,930 ) Total — (286,669 ) — (168,930 ) December 31, 2014 Description Level 1 $ Level 2 $ Level 3 $ Total Gains and (Losses) $ Derivative liability — (237,061 ) — (82,138 ) Total — (237,061 ) — (82,138 ) December 31, 2015 Description Level 1 $ Level 2 $ Level 3 $ Total Gains and (Losses) $ Derivative liability — (292,320 ) — (202,193 ) Total — (292,320 ) — (202,193 ) n) Foreign Currency Translation The Company’s functional and reporting currency is the United States dollar. Monetary assets and liabilities denominated in foreign currencies are translated in accordance with ASC 830 Foreign Currency Translation Matters, o) Recent Accounting Pronouncements The Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

Property and Equipment

Property and Equipment	12 Months Ended
	Dec. 31, 2015
Property, Plant and Equipment [Abstract]
Property and Equipment	3. Property and Equipment Net Book Value Cost $ Accumulated Depreciation $ December 31, 2015 $ December 31, 2014 $ December 31, 2013 $ Equipment 47,861 45,599 2,262 5,885 9,914 During the year ended December 31, 2015, $3,623 (2014 - $4,029; 2013 - $5,221) of depreciation expense had been recorded.

Convertible Debentures

Convertible Debentures	12 Months Ended
	Dec. 31, 2015
Debt Disclosure [Abstract]
Convertible Debentures	4. Convertible Debentures a) In February 2013, the Company issued a convertible debenture to a non-related party for $37,500. Under the terms of the note, the amount owing is unsecured, due interest of 8% per annum, and matures on November 15, 2013. The note is convertible into shares of common stock 180 days after the date of issuance (August 14, 2013) at a conversion rate of 58% of the average of the three lowest bid prices of the Company’s common stock for the ten trading days ending one trading day prior to the date of the conversion notice is sent by the holder of the Company. Due to this provision, the embedded conversion option qualifies for derivative accounting under ASC 815-15 “Derivatives and Hedging”. The fair value of the derivative liability resulted in a full discount to the note payable of $28,810. The carrying value of the convertible note will be accreted over the term of the convertible note up to the value of $37,500. During the year ended December 31, 2013, the Company issued 2,349,367 shares of common stock for the conversion of $37,500 of the note and $1,500 of accrued interest. During the year ended December 31, 2013, $28,810 (2012 - $nil) of accretion expense had been recorded and the note has been fully converted. The Company paid financing costs of $2,500 relating to the issuance of the note. b) In April 2013, the Company issued a convertible debenture to a non-related party for $32,500. Under the terms of the note, the amount owing is unsecured, due interest of 8% per annum, and matures on January 15, 2014. The note is convertible into shares of common stock 180 days after the date of issuance (October 7, 2013) at a conversion rate of 58% of the average of the three lowest bid prices of the Company’s common stock for the ten trading days ending one trading day prior to the date of the conversion notice is sent by the holder of the Company. 4. Convertible Debentures Due to this provision, the embedded conversion option qualifies for derivative accounting under ASC 815-15 “Derivatives and Hedging”. The fair value of the derivative liability resulted in a full discount to the note payable of $24,979. The carrying value of the convertible note will be accreted over the term of the convertible note up to the value of $32,500. During the year ended December 31, 2013, the Company issued 1,716,573 shares of common stock for the conversion of $32,500 of the note and $1,300 of accrued interest. During the year ended December 31, 2013, $24,979 (2012 - $nil) of accretion expense had been recorded and the note has been fully converted. The Company paid financing costs of $2,500 relating to the issuance of the note. c) In June 2013, the Company issued a convertible debenture to a non-related party for $32,500. Under the terms of the note, the amount owing is unsecured, due interest of 8% per annum, and matures on March 5, 2014. The note is convertible into shares of common stock 180 days after the date of issuance (November 30, 2013) at a conversion rate of 58% of the average of the three lowest bid prices of the Company’s common stock for the ten trading days ending one trading day prior to the date of the conversion notice is sent by the holder of the Company. Due to this provision, the embedded conversion option qualifies for derivative accounting under ASC 815-15 “Derivatives and Hedging”. The fair value of the derivative liability resulted in a full discount to the note payable of $24,953. The carrying value of the convertible note will be accreted over the term of the convertible note up to the value of $32,500. During the year ended December 31, 2013, the Company issued 2,312,268 shares of common stock for the conversion of $32,500 of the note and $1,300 of accrued interest. During the year ended December 31, 2013, $24,953 (2012 - $nil) of accretion expense had been recorded and the note has been fully converted. The Company paid financing costs of $2,500 relating to the issuance of the note. d) In August 2013, the Company issued a convertible debenture to a non-related party for $32,500. Under the terms of the note, the amount owing is unsecured, bears interest at 8% per annum, and matures on May 5, 2014. The note is convertible into shares of common stock 180 days after the date of issuance (January 28, 2014) at a conversion rate of 58% of the average of the three lowest bid prices of the Company’s common stock for the ten trading days ending one trading day prior to the date of the conversion notice is sent by the holder of the Company. The Company incurred financing costs of $2,500 in connection with the financing, which was deferred and is being amortized over the term of the debt. During the year ended December 31, 2015, the Company amortized $nil (2014 - $1,103; 2013 - $1,397) of the deferred financing costs. Due to this provision, the embedded conversion option qualifies for derivative accounting under ASC 815-15 “Derivatives and Hedging”. The fair value of the derivative liability resulted in a discount to the note payable of $32,500. The carrying value of the convertible note will be accreted over the term of the convertible note up to the value of $32,500. During the year ended December 31, 2014, the Company issued 1,306,199 shares of common stock for the conversion of $32,500 of the note and $1,300 of accrued interest. During the year ended December 31, 2015, $nil (2014 - $14,445; 2013 - $18,055) of accretion expense had been recorded and the note has been fully converted. e) In October 2013, the Company issued a convertible debenture to a non-related party for $32,500. Under the terms of the note, the amount owing is unsecured, bears interest at 8% per annum, and matures on July 5, 2014. The note is convertible into shares of common stock 180 days after the date of issuance (March 30, 2014) at a conversion rate of 58% of the average of the three lowest bid prices of the Company’s common stock for the ten trading days ending one trading day prior to the date of the conversion notice is sent by the holder of the Company. The Company incurred financing costs of $2,500 in connection with the financing, which was deferred and is being amortized over the term of the debt. During the year ended December 31, 2015, the Company amortized $nil (2014 - $1,664; 2013 - $836) of the deferred financing costs. 4. Convertible Debentures Due to this provision, the embedded conversion option qualifies for derivative accounting under ASC 815-15 “Derivatives and Hedging”. The fair value of the derivative liability resulted in a discount to the note payable of $32,500. The carrying value of the convertible note will be accreted over the term of the convertible note up to the value of $32,500. During the year ended December 31, 2014, the Company issued 1,687,097 shares of common stock for the conversion of $32,500 of the note and $1,300 of accrued interest. During the year ended December 31, 2015, $nil (2014 - $21,667; 2013 - $10,833) of accretion expense had been recorded and the note has been fully converted. f) In October 2013, the Company issued a convertible debenture to a non-related party for $32,500. Under the terms of the note, the amount owing is unsecured, bears interest at 8% per annum, and matures on August 4, 2014. The note is convertible into shares of common stock 180 days after the date of issuance (April 29, 2014) at a conversion rate of 58% of the average of the three lowest bid prices of the Company’s common stock for the ten trading days ending one trading day prior to the date of the conversion notice is sent by the holder of the Company. The Company incurred financing costs of $2,500 in connection with the financing, which was deferred and is being amortized over the term of the debt. During the year ended December 31, 2015, the Company amortized $nil (2014 - $1,939; 2013 - $561) of the deferred financing costs. Due to this provision, the embedded conversion option qualifies for derivative accounting under ASC 815-15 “Derivatives and Hedging”. The fair value of the derivative liability resulted in a full discount to the note payable of $32,500. The carrying value of the convertible note will be accreted over the term of the convertible note up to the value of $32,500. During the year ended December 31, 2014, the Company issued 1,442,781 shares of common stock for the conversion of $32,500 of the note and $1,300 of accrued interest. During the year ended December 31, 2015, $nil (2014 - $25,278; 2013 - $7,222) of accretion expense had been recorded and the note has been fully converted. g) In December 2013, the Company issued a convertible debenture to a non-related party for $32,500. Under the terms of the note, the amount owing is unsecured, bears interest at 8% per annum, and matures on September 19, 2014. The note is convertible into shares of common stock 180 days after the date of issuance (June 15, 2014) at a conversion rate of 58% of the average of the three lowest bid prices of the Company’s common stock for the ten trading days ending one trading day prior to the date of the conversion notice is sent by the holder of the Company. The Company incurred financing costs of $2,500 in connection with the financing, which was deferred and is being amortized over the term of the debt. During the year ended December 31, 2015, the Company amortized $nil (2014 - $2,372; 2013 - $128) of the deferred financing costs. Due to this provision, the embedded conversion option qualifies for derivative accounting under ASC 815-15 “Derivatives and Hedging”. The fair value of the derivative liability resulted in a discount to the note payable of $32,500. The carrying value of the convertible note will be accreted over the term of the convertible note up to the value of $32,500. During the year ended December 31, 2014, the Company issued 1,383,394 shares of common stock for the conversion of $32,500 of the note and $1,300 of accrued interest. During the year ended December 31, 2015, $nil (2014 - $30,694; 2013 - $1,806) of accretion expense had been recorded and the note has been fully converted. h) In January 2014, the Company issued a convertible debenture to a non-related party for $37,500. Under the terms of the note, the amount owing is unsecured, bears interest at 8% per annum, and matures on October 14, 2014. The note is convertible into shares of common stock 180 days after the date of issuance (July 9, 2014) at a conversion rate of 58% of the average of the three lowest bid prices of the Company’s common stock for the ten trading days ending one trading day prior to the date of the conversion notice is sent by the holder of the Company. The Company incurred financing costs of $2,500 in connection with the financing, which was deferred and is being amortized over the term of the debt. During the year ended December 31, 2015, the Company amortized $nil (2014 - $2,500) of the deferred financing costs. 4. Convertible Debentures Due to this provision, the embedded conversion option qualifies for derivative accounting under ASC 815-15 “Derivatives and Hedging”. The fair value of the derivative liability resulted in a full discount to the note payable of $37,500. The carrying value of the convertible note will be accreted over the term of the convertible note up to the value of $37,500. During the year ended December 31, 2014, the Company issued 1,906,938 shares of common stock for the conversion of $37,500 of the note and $1,500 of accrued interest. During the year ended December 31, 2015, $nil (2014 - $37,500) of accretion expense had been recorded and the note has been fully converted. i) In March 2014, the Company issued a convertible debenture to a non-related party for $32,500. Under the terms of the note, the amount owing is unsecured, bears interest at 8% per annum, and matures on December 26, 2014. The note is convertible into shares of common stock 180 days after the date of issuance (September 15, 2014) at a conversion rate of 58% of the average of the three lowest bid prices of the Company’s common stock for the ten trading days ending one trading day prior to the date of the conversion notice is sent by the holder of the Company. The Company incurred financing costs of $2,500 in connection with the financing, which was deferred and is being amortized over the term of the debt. During the year ended December 31, 2015, the Company amortized $nil (2014 - $2,500) of the deferred financing costs. Due to this provision, the embedded conversion option qualifies for derivative accounting under ASC 815-15 “Derivatives and Hedging”. The fair value of the derivative liability resulted in a full discount to the note payable of $32,500. The carrying value of the convertible note will be accreted over the term of the convertible note up to the value of $32,500. During the year ended December 31, 2014, the Company issued 3,318,215 shares of common stock for the conversion of $32,500 of the note and $1,700 of accrued interest. During the year ended December 31, 2015, $nil (2014 - $32,500) of accretion expense had been recorded and the note has been fully converted. j) In May 2014, the Company issued a convertible debenture to a non-related party for $42,500. Under the terms of the note, the amount owing is unsecured, bears interest at 8% per annum, and matures on February 16, 2015. The note is convertible into shares of common stock 180 days after the date of issuance (November 10, 2014) at a conversion rate of 58% of the average of the three lowest bid prices of the Company’s common stock for the ten trading days ending one trading day prior to the date of the conversion notice is sent by the holder of the Company. The Company incurred financing costs of $2,500 in connection with the financing, which was deferred and is being amortized over the term of the debt. During the year ended December 31, 2015, the Company amortized $423 (2014 - $2,077) of the deferred financing costs. Due to this provision, the embedded conversion option qualifies for derivative accounting under ASC 815-15 “Derivatives and Hedging”. The fair value of the derivative liability resulted in a full discount to the note payable of $42,500. The carrying value of the convertible note will be accreted over the term of the convertible note up to the value of $42,500. During the year ended December 31, 2014, the Company issued 3,980,077 shares of common stock for the conversion of $42,500 of the note and $1,300 of accrued interest. During the year ended December 31, 2015, $nil (2014 - $42,500) of accretion expense had been recorded and the note has been fully converted. k) In June 2014, the Company issued a convertible debenture to a non-related party for $68,000. Under the terms of the note, the amount owing is unsecured, bears interest at 8% per annum, and matures on March 18, 2015. The note is convertible into shares of common stock 180 days after the date of issuance (December 13, 2014) at a conversion rate of 58% of the average of the three lowest bid prices of the Company’s common stock for the ten trading days ending one trading day prior to the date of the conversion notice is sent by the holder of the Company. The Company incurred financing costs of $3,000 in connection with the financing, which was deferred and is being amortized over the term of the debt. During the year ended December 31, 2015, the Company amortized $840 (2014 - $2,160) of the deferred financing costs. 4. Convertible Debentures Due to this provision, the embedded conversion option qualifies for derivative accounting under ASC 815-15 “Derivatives and Hedging”. The fair value of the derivative liability resulted in a full discount to the note payable of $68,000. The carrying value of the convertible note will be accreted over the term of the convertible note up to the value of $68,000. During the year ended December 31, 2014, the Company issued 3,402,974 shares of common stock for the conversion of $30,000 of the note. During the year ended December 31, 2015, the Company issued 5,735,211 shares of common stock for the conversion of $38,000 of the note and $2,720 of accrued interest. During the year ended December 31, 2015, $17,000 (2014 - $51,000) of accretion expense had been recorded. l) In July 2014, the Company issued a convertible debenture to a non-related party for $42,500. Under the terms of the note, the amount owing is unsecured, bears interest at 8% per annum, and matures on April 11, 2015. The note is convertible into shares of common stock 180 days after the date of issuance (January 5, 2015) at a conversion rate of 58% of the average of the three lowest bid prices of the Company’s common stock for the ten trading days ending one trading day prior to the date of the conversion notice is sent by the holder of the Company. The Company incurred financing costs of $2,500 in connection with the financing, which was deferred and is being amortized over the term of the debt. During the year ended December 31, 2015, the Company amortized $915 (2014 - $1,585) of the deferred financing costs. Due to this provision, the embedded conversion option qualifies for derivative accounting under ASC 815-15 “Derivatives and Hedging”. The fair value of the derivative liability resulted in a full discount to the note payable of $42,500. The carrying value of the convertible note will be accreted over the term of the convertible note up to the value of $42,500. During the year ended December 31, 2015, the Company issued 6,075,118 shares of common stock for the conversion of $42,500 of the note and $1,700 of accrued interest. During the year ended December 31, 2015, $18,889 (2014 - $23,611) of accretion expense had been recorded. m) In October 2014, the Company issued a convertible debenture to a non-related party for $38,000. Under the terms of the note, the amount owing is unsecured, bears interest at 8% per annum, and matures on July 28, 2015. The note is convertible into shares of common stock 180 days after the date of issuance (April 22, 2015) at a conversion rate of 58% of the average of the three lowest bid prices of the Company’s common stock for the ten trading days ending one trading day prior to the date of the conversion notice is sent by the holder of the Company. The Company incurred financing costs of $3,000 in connection with the financing, which was deferred and is being amortized over the term of the debt. During the year ended December 31, 2015, the Company amortized $2,264 (2014 - $736) of the deferred financing costs. Due to this provision, the embedded conversion option qualifies for derivative accounting under ASC 815-15 “Derivatives and Hedging”. The fair value of the derivative liability resulted in a full discount to the note payable of $38,000. The carrying value of the convertible note will be accreted over the term of the convertible note up to the value of $38,000. During the year ended December 31, 2015, the Company repaid $13,780 of the note with cash and issued 4,947,683 shares of common stock for the conversion of $28,830 of the note and $1,520 of accrued interest. During the year ended December 31, 2015, the Company defaulted on the loan and recorded an additional $4,610 to interest expense as a result. During the year ended December 31, 2015, $29,556 (2014 - $8,444) of accretion expense had been recorded. n) In January 2015, the Company issued a $43,000 convertible debenture to a non-related party, in exchange for proceeds of $41,500, net of an original issuance discount of $1,500. Under the terms of the note, the amount owing is unsecured, bears interest of at 10% per annum, and matures on January 5, 2016. The note is convertible into shares of common stock immediately at a conversion rate of 58% of the average of the three lowest bid prices of the Company’s common stock for the ten trading days ending one trading day prior to the date of the conversion notice is sent by the holder of the Company. The Company incurred financing costs of $1,500 in connection with the financing, which was deferred and is being amortized over the term of the debt. During the year ended December 31, 2015, the Company amortized $1,484 (2014 - $nil) of the deferred financing costs. 4. Convertible Debentures Due to this provision, the embedded conversion option qualifies for derivative accounting under ASC 815-15 “Derivatives and Hedging”. The fair value of the derivative liability resulted in a full discount to the note payable of $40,000. The carrying value of the convertible note will be accreted over the term of the convertible note up to the value of $43,000. During the year ended December 31, 2015, the Company issued 7,186,111 shares of common stock for the conversion of $43,000 of the note and $2,704 of accrued interest. During the year ended December 31, 2015, $40,000 (2014 - $nil) of accretion expense had been recorded. o) In July 2015, the Company issued a $46,000 convertible debenture to a non-related party, in exchange for proceeds of $42,500, net of an original issuance discount of $3,500. Under the terms of the note, the amount owing is unsecured, bears interest at 10% per annum, and matures on July 7, 2016. The note is convertible into shares of common stock immediately at a conversion rate of 58% of the lowest bid price of the Company’s common stock for the ten trading days ending one trading day prior to the date of the conversion notice is sent by the holder of the Company. The Company incurred financing costs of $1,500 in connection with the financing, which was deferred and is being amortized over the term of the debt. During the year ended December 31, 2015, the Company amortized $730 (2014 - $nil) of the deferred financing costs. Due to this provision, the embedded conversion option qualifies for derivative accounting under ASC 815-15 “Derivatives and Hedging”. The fair value of the derivative liability resulted in a discount to the note payable of $6,265. The carrying value of the convertible note will be accreted over the term of the convertible note up to the value of $46,000. During the year ended December 31, 2015, $3,133 (2014 - $nil) of accretion expense had been recorded. p) In August 2015, the Company issued a convertible debenture to a non-related party for up to $250,000, with an original issuance discount of 10% which will be deferred and accreted over the term of the debenture. Under the terms of the note, the amount owing is unsecured, bears one-time interest at 12%, and matures two years from the date the proceeds were received. The note is convertible into shares of common stock immediately at a conversion rate of the lesser of $0.0131 or 60% of average of the three lowest bid prices of the Company’s common stock for the twenty trading days ending one trading day prior to the date of the conversion notice is sent by the holder of the Company. In August 2015, the Company received proceeds under the first tranche of this convertible note of $55,556 consisting of proceeds of $50,000 net of an original issuance discount of $5,556. Due to this provision, the embedded conversion option qualifies for derivative accounting under ASC 815-15 “Derivatives and Hedging”. The fair value of the derivative liability resulted in a full discount to the note payable of $55,556. The carrying value of the convertible note will be accreted over the term of the convertible note up to the value of $55,556. During the year ended December 31, 2015, $23,148 (2014 - $nil) of accretion expense had been recorded. In December 2015, the Company received proceeds under the second tranche of this convertible note of $27,778 consisting of proceeds of $25,000 net of an original issuance discount of $2,778. Due to this provision, the embedded conversion option qualifies for derivative accounting under ASC 815-15 “Derivatives and Hedging”. The fair value of the derivative liability resulted in a full discount to the note payable of $27,778. The carrying value of the convertible note will be accreted over the term of the convertible note up to the value of $27,778. During the year ended December 31, 2015, $1,157 (2014 - $nil) of accretion expense had been recorded. 4. Convertible Debentures q) In September 2015, the Company issued a $33,500 convertible debenture to a non-related party, in exchange for $31,000, net of an original issuance discount of $2,500. Under the terms of the note, the amount owing is unsecured, bears interest at 10% per annum, and matures on September 28, 2016. The note is convertible into shares of common stock immediately at a conversion rate of 58% of average of the two lowest bid prices of the Company’s common stock for the ten trading days ending one trading day prior to the date of the conversion notice is sent by the holder of the Company. The Company incurred financing costs of $1,000 in connection with the financing, which was deferred and is being amortized over the term of the debt. During the year ended December 31, 2015, the Company amortized $260 (2014 - $nil) of the deferred financing costs. Due to this provision, the embedded conversion option qualifies for derivative accounting under ASC 815-15 “Derivatives and Hedging”. The fair value of the derivative liability resulted in a discount to the note payable of $4,775. The carrying value of the convertible note will be accreted over the term of the convertible note up to the value of $33,500. During the year ended December 31, 2015, $1,194 (2014 - $nil) of accretion expense had been recorded.

Derivative Liability

Derivative Liability	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Derivative Liability	5. Derivative Liability The Company records the fair value of the reset provision of its exercise price of share purchase warrants in accordance with ASC 815, Derivatives and Hedging During the year ended December 31, 2011, the Company issued warrants with an exercise price of $0.10 per share until July 14, 2014, and the reset provision allows for the exercise price to be reset to a value equal to a future issuance of common shares, stock options, warrants, or other equity instrument if the issuance or exercise price is less than $0.10 per share. The Company uses a Black-Scholes model to fair value the derivative liability associated with the reset provision. As the warrants expired unexercised on July 14, 2014, the Company removed the derivative liability and recognized a gain of $127,451. During the year ended December 31, 2015, the Company recorded a gain on fair value of derivatives of $nil (2014 –$127,451). During the year ended December 31, 2015, the Company issued convertible debentures with a variable exercise price based on future market rates. The Company uses a multi-nominal lattice model to fair value the derivative liability associated with the variable exercise price. As at December 31, 2015, the Company recorded a derivative liability of $292,320 (2014 - $237,061; 2013 - $286,679). During the year ended December 31, 2015, the Company recorded a loss on fair value of derivatives of $202,193 (2014 – $209,589). During the year ended December 31, 2013, the Company utilized an expected volatility which ranged from 270% to 316%, risk-free rate of 1.00%, expected divided yield of 0%, and expected life which ranged from 0.5 to 3.0 years to calculate the total derivative liability of $286,679. During the year ended December 31, 2014, the Company utilized an expected volatility which ranged from 194% to 316%, risk-free rate which ranged from 0.01% to 0.15%, expected divided yield of 0%, and expected life which ranged from 0.2 to 0.77 years to calculate the total derivative liability of $237,061. During the year ended December 31, 2015, the Company utilized an expected volatility which ranged from 182% to 304%, risk-free rate which ranged from 0.01% to 1.06%, expected divided yield of 0%, and expected life which ranged from 0.08 to 2.0 years to calculate the total derivative liability of $292,320. A summary of the activity of the derivative liability is shown below: $ Balance at December 31, 2012 26,627 Debt discount 124,902 Derivative due to mark to market adjustment 135,150 Balance at December 31, 2013 286,679 Derivative loss due to new issuances 122,265 Debt discount 261,000 Reclass to share capital (355,825 ) Derivative due to mark to market adjustment (77,058 ) Balance at December 31, 2014 237,061 Derivative loss due to new issuances 91,358 Debt discount 137,374 Reclass to share capital (282,806 ) Derivative due to mark to market adjustment 109,333 Balance at December 31, 2015 292,320

Common Shares and Common Stock

Common Shares and Common Stock Subscribed	12 Months Ended
	Dec. 31, 2015
Equity [Abstract]
Common Shares and Common Stock Subscribed	6. Common Shares Year Ended December 31, 2015 a) On February 2, 2015, the Company issued 10,000,000 common shares at $0.01 per share for total cash proceeds of $100,000. b) On February 2, 2015, the Company issued 500,000 common shares for services provided with a fair value of $5,900. The fair value of the shares was determined by using the end of day trading price of the Company’s common shares on the date of the agreement. c) On March 20, 2015, the Company issued 5,000,000 common shares at $0.01 per share for total cash proceeds of $50,000. d) During the year ended December 31, 2015, the Company issued an aggregate of 23,944,123 common shares upon the conversion of $442,282 of convertible notes payable and accrued interest. Year Ended December 31, 2014 e) On May 19, 2014, the Company issued 69,000,000 common shares for proceeds of $100,000 pursuant to the December 13, 2013 shares exchange agreement with Eurogas, Inc., as amended on January 13 and May 13, 2014. f) During the year ended December 31, 2014, the Company issued an aggregate of 2,000,000 common shares for services provided. The fair value of the shares issued of $88,190 was determined by using the end of day trading price of the Company’s common shares on the dates of the agreements. g) During the year ended December 31, 2014, the Company issued an aggregate of 18,427,675 common shares upon the conversion of $683,856 of convertible notes payable and accrued interest. Year Ended December 31, 2013 h) On January 7, 2013, the Company issued 675,000 common shares with a fair value of $11,475 for director services. Fair value of the common shares was determined by using the end of day trading price on the date of authorization. i) On June 20, 2013, the Company issued 6,500,000 common shares at $0.01 per share for total cash proceeds of $65,000. j) On June 20, 2013, the Company issued 5,200,000 common shares with a fair value of $52,000 for settlement of related party payables. Fair value of the common shares was determined using the share prices of shares issued for cash proceeds on the same date. k) On August 23, 2013, the Company issued an aggregate of 6,378,208 common shares upon the conversion of $228,727 of convertible notes payable and accrued interest. 7. Common Stock Subscribed a) On August 31, 2011, the Company received proceeds of $50,000 for the issuance of common shares. The details of the subscription were to be agreed upon at a later date and have not be yet been finalized. b) On December 21, 2015, the Company received proceeds of $50,000 for the issuance of 5,000,000 common shares at $0.01 per share. The common shares were issued on January 11, 2016. Refer to Note 12(a). c) On December 28, 2015, the Company received proceeds of $100,000 for the issuance of 10,000,000 common shares at $0.01 per share. The common shares were issued on January 11, 2016. Refer to Note 12(a). In connection with this financing, the Company incurred share issuance costs of $10,000.

Contingencies

Contingencies	12 Months Ended
	Dec. 31, 2015
Commitments and Contingencies Disclosure [Abstract]
Contingencies	8. Contingencies On December 13, 2013, the Company entered into a share exchange agreement (the “Agreement”) with EuroGas, Inc., a company incorporated in the state of Utah, and EuroGas AG, a company incorporated in Switzerland. Under the terms of the Agreement, the Company would acquire 240,000,000 common shares of EuroGas AG, representing approximately 26% of the issued and outstanding common shares, and pay $5,000,000 within 9 months of the closing date of the Agreement, in exchange for the issuance of 348,000,000 common shares of the Company. The transaction would result the shareholders of EuroGas Inc. and EuroGas AG holding more than 50% of the issued and outstanding common shares of the Company. On January 13, 2014, the Company amended the terms of the December 13, 2013 agreement to include proceeds of 20% of any settlement liability EuroGas Inc. and EuroGas AG receives in its current litigation against the Slovak Republic. On May 13, 2014, the Company amended the terms of the December 13, 2013 agreement whereby the Company would receive $100,000 (received) in exchange for the issuance of 69,000,000 common shares (issued) of the Company and the remaining 279,000,000 common shares of the Company to be issued by June 13, 2014 in exchange for 240,000,000 common shares of EuroGas AG and $400,000, with further payments to the Company of $500,000 on or before August 30, 2014, and the final payment of $4,000,000 on or before October 31, 2014. On August 21, 2014, the Company filed a lawsuit against EuroGas, Inc., EuroGas AG and ZB Capital, AG as well as an injunction against these parties, their agents, or anyone associated from redeeming the share certificate and trading, selling, transferring or pledging the common shares issued. On November 19, 2014, the parties entered into an Extension Agreement whereby the Company would dismiss the lawsuit and release the share certificate to ZB Capital AG within ten days of the Effective Date and EuroGas, Inc. and EuroGas AG would remit a single payment of $400,000 to the Company on or before January 2, 2015. The parties also agreed to revise the payment date for the remaining $4,500,000 financing to a date on or before 120 days from the Effective Date of the agreement and that all other terms and conditions of the original agreement and the amendments would remain the same. On signing the agreement the Company recorded a receivable for the $400,000 amount owing and a corresponding gain on settlement of debt. On March 27, 2015, the Company refiled its lawsuit against EuroGas, Inc., EuroGas AG, and ZB Capital AG. As at December 31, 2015, the Company had not received the $400,000 owing from EuroGas, Inc. and recorded an allowance to offset the amount receivable along with a corresponding loss on settlement of debt.

Share Purchase Warrants

Share Purchase Warrants	12 Months Ended
	Dec. 31, 2015
Equity [Abstract]
Share Purchase Warrants	9. Share Purchase Warrants The following table summarizes the continuity schedule for share purchase warrants: Exercise Price Number of Warrants $ Balance – December 31, 2012 18,500,000 0.10 Expired (2,500,000) 0.10 Balance – December 31, 2013 16,000,000 Expired (16,000,000) Balance – December 31, 2014 and 2015 — —

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2015
Related Party Transactions [Abstract]
Related Party Transactions	10. Related Party Transactions As at December 31, 2015, the Company owed $4,408 (2014 - $3,950; 2013 - $10,654) to the President of the Company for management fees incurred and financing of day-to-day operations. The amounts owing are unsecured, non-interest bearing, and due on demand. During the year ended December 31, 2015, the Company incurred $135,000 (2014 - $120,000; 2013 - $120,000) to the President of the Company for management fees.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2015
Income Tax Disclosure [Abstract]
Income Taxes	11. Income Taxes The Company has $9,803,800 of net operating losses to carry forward to offset taxable income in future years which expire through fiscal 2035. For the years ended December 31, 2015, 2014, and 2013, the valuation allowance established against the deferred tax assets increased by $124,292, $151,267, and $82,201, respectively. The components of the net deferred tax asset at December 31, 2015, 2014, and 2013, the statutory tax rate, the effective tax rate and the amount of the valuation allowance are indicated below: 2015 2014 2013 $ $ $ Loss Before Taxes (716,943 ) (808,710 ) (523,784 ) Statutory rate 34 % 34 % 34 % Computed expected tax recovery (243,761 ) (274,961 ) (178,087 ) Non-deductible expenses 119,469 123,694 95,886 Change in valuation allowance 124,292 151,267 82,201 Income tax expense — — — 2015 2014 2013 $ $ $ Deferred tax asset Cumulative net operating losses 3,352,372 3,228,080 3,076,813 Less valuation allowance (3,352,372 ) (3,228,080 ) (3,076,813 ) Net deferred tax asset — — — The following table lists the fiscal year in which the loss was incurred and the expiration date of the operating: Expiration Net Date of Loss Operating Period Incurred $ Losses December 31, 2006 159,600 2026 December 31, 2007 2,310,000 2027 December 31, 2008 2,638,800 2028 December 31, 2009 1,665,000 2029 December 31, 2010 944,400 2030 December 31, 2011 631,600 2031 December 31, 2012 391,900 2032 December 31, 2013 252,000 2033 December 31, 2014 444,900 2034 December 31, 2015 365,600 2035 9,803,800

Restatement

Restatement	12 Months Ended
	Dec. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Restatement	12. Restatement The Company has restated its consolidated financial statements for the years ended December 31, 2014 and 2013 to reflect the accretion of the discount and interest on the convertible debentures and derivative liabilities. This restatement resulted in an increase to net loss of $96,623 with no change in net loss per share. The impact of the restatement as at December 31, 2014, and for the years ended December 31, 2014 and 2013 is summarized below: Consolidated Balance Sheet As at December 31, 2014 As Reported $ Adjustment $ As Restated $ LIABILITIES AND STOCKHOLDERS’ DEFICIT Current liabilities Convertible debentures, net of unamortized discount 16,098 36,957 53,055 Total liabilities 267,757 36,957 304,714 Stockholders’ Deficit Common stock 18,734,351 141,477 18,875,828 Accumulated deficit (24,004,261 ) (178,434 ) (24,182,695 ) Total stockholders’ deficit (254,068 ) (36,957 ) (291,025 ) Total liabilities and stockholders’ deficit 13,689 — 13,689 Consolidated Statement of Operations Year Ended December 31, 2014 As Reported $ Adjustment $ As Restated $ Operating loss (417,491 ) (65,000 ) (482,491 ) Other income (expense) Gain (loss) on conversion of debt (7,130 ) 7,130 — Gain on forgiveness of debt — 65,000 65,000 Loss on change in fair value of derivative liabilities (45,207 ) (36,931 ) (82,138 ) Accretion and interest expense (242,259 ) (66,822 ) (309,081 ) Total other income (expense) (294,596 ) (31,623 ) (326,219 ) Net loss (712,087 ) (96,623 ) (808,710 ) Year Ended December 31, 2013 As Reported $ Adjustment $ As Restated $ Other income (expense) Accretion and interest expense (113,826 ) (13,705 ) (127,531 ) Loss on change in fair value of derivative liabilities (100,824 ) (68,106 ) (168,930 ) Total other income (expense) (214,650 ) (81,811 ) (296,461 ) Net loss (441,973 ) (81,811 ) (523,784 ) Consolidated Statements of Stockholders' Deficit As at December 31, 2014 As Reported $ Adjustment $ As Restated $ Common stock 18,734,351 141,477 18,875,828 Accumulated deficit (24,004,261 ) (178,434 ) (24,182,695 ) Total (254,068 ) (36,957 ) (291,025 ) As at December 31, 2013 As Reported $ Adjustment $ As Restated $ Common stock 17,956,296 47,485 18,003,782 Accumulated deficit (23,292,174 ) (81,811 ) (23,373,985 ) Total (320,035 ) (34,326 ) (354,361 ) Consolidated Statement of Cash Flows Year Ended December 31, 2014 As Reported $ Adjustment $ As Restated $ Operating Activities Net loss (712,087 ) (96,623 ) (808,710 ) Adjustments to reconcile net loss to net cash used in operating activities: Accretion expense 229,717 57,922 287,639 Gain (loss) on conversion of debt 7,130 (7,130 ) — Loss on change in fair value of derivative liabilities 45,207 36,931 82,138 Changes in operating assets and liabilities: Deferred financing costs 2,637 24,899 27,536 Accounts payable and accrued liabilities 5,684 1 5,685 Net cash used in operating activities (394,493 ) 16,000 (378,493 ) Financing Activities Proceeds from issuance of convertible debt 261,000 (16,000 ) 245,000 Net cash provided by financing activities 354,296 (16,000 ) 338,296 Year Ended December 31, 2013 As Reported $ Adjustment $ As Restated $ Operating Activities Net loss (441,973 ) (81,811 ) (523,784 ) Adjustments to reconcile net loss to net cash used in operating activities: Accretion expense 113,826 13,705 127,531 Loss on change in fair value of derivative liabilities 100,824 68,106 168,930

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2015
Subsequent Events [Abstract]
Subsequent Events	13. Subsequent Events a) On January 11, 2016, the Company issued 15,000,000 common shares at $0.01 per share for total cash proceeds of $150,000, which was recorded as common stock subscribed as at December 31, 2015. b) On January 15, 2016, the Company issued 2,068,965 common shares upon the conversion of $12,000 of convertible notes payable. c) On February 4, 2016, the Company entered into a subscription agreement for the issuance of 5,000,000 common shares at $0.01 per share for gross proceeds of $50,000. d) On February 12, 2016, the Company issued 1,000,000 common shares upon the conversion of $5,300 of convertible notes payable. e) On February 19, 2016, the Company issued 2,298,850 common shares upon the conversion of $12,000 of convertible notes payable. f) On February 25, 2016, the Company issued 1,100,000 common shares upon the conversion of $5,544 of convertible notes payable. g) On March 2, 2016, the Company issued 2,686,968 common shares upon the conversion of $12,000 of convertible notes payable. h) On March 3, 2016, the Company issued 1,400,000 common shares upon the conversion of $6,636 of convertible notes payable. i) On March 10, 2016, the Company issued 1,800,000 common shares upon the conversion of $8,316 of convertible notes payable. j) On April 5, 2016, the Company issued 2,500,000 common shares upon the conversion of $10,650 of convertible notes payable. k) On April 26, 2016, the Company issued 3,029,556 common shares upon the conversion of $10,000 of convertible notes payable and $2,300 of accrued interest.

Summary of Significant Accoun19

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2015
Accounting Policies [Abstract]
Basis of Presentation and Principles of Consolidation	a) Basis of Presentation and Principles of Consolidation These consolidated financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States, and are expressed in US dollars. The consolidated financial statements include the accounts of the Company and its subsidiary, Tombstone Mining and Exploration Corporation. All inter-company accounts and transactions have been eliminated. The Company’s fiscal year-end is December 31.
Use of Estimates	b) Use of Estimates The preparation of these consolidated financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the useful life and recoverability of long lived assets, fair value of stock-based compensation, valuation of convertible debentures and derivative liabilities, and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.
Cash and Cash Equivalents	c) Cash and Cash Equivalents The Company considers all highly liquid instruments with maturity of three months or less at the time of issuance to be cas h equivalents. As at December 31, 2015 and 2014, the Company had no cash equivalents.
Property and Equipment	d) Property and Equipment Property and equipment are recorded at the lower of cost or net book value, and are amortized based on the following rates: Equipment 5 years straight-line
Impairment of Long-Lived Assets	e) Impairment of Long-Lived Assets In accordance with ASC 360, Property Plant and Equipment
Mineral Properties	f) Mineral Properties Mineral property acquisition and exploration costs are expensed as incurred. When it has been determined that a mineral property can be economically developed as a result of establishing proven and probable reserves, the costs incurred to develop such property are capitalized. Such costs will be amortized using the units-of-production method over the estimated life of the probable reserve. If mineral properties are subsequently abandoned or impaired, any capitalized costs will be charged to operations.
Stock-Based Compensation	g) Stock-Based Compensation The Company records stock-based compensation in accordance with ASC 505, Equity Share-Based Payments
Revenue Recognition	h) Revenue Recognition The Company recognizes revenue in accordance with ASC 605, Revenue Recognition.
Income Taxes	i) Income Taxes Potential benefits of income tax losses are not recognized in the accounts until realization is more likely than not. The Company has adopted ASC 740, Accounting for Income Taxes,
Comprehensive Loss	j) Comprehensive Loss ASC 220, Comprehensive Income,
Derivative Liability	k) Derivative Liability From time to time, the Company may issue equity instruments that may contain an embedded derivative instrument which may result in a derivative liability. A derivative liability exists on the date the equity instrument is issued when there is a contingent exercise provision. The derivative liability is recorded at its fair value calculated by using an option pricing model such as a multi-nominal lattice model or Black-Scholes model. The fair value of the derivative liability is then calculated on each balance sheet date with the corresponding gains and losses recorded in the consolidated statement of operations.
Basic and Diluted Net Income (Loss) Per Share	l) Basic and Diluted Net Income (Loss) Per Share The Company computes net income (loss) per share in accordance with ASC 260, Earning per Share
Financial Instruments	m) Financial Instruments Pursuant to ASC 820, Fair Value Measurements and Disclosures Financial Instruments Level 1 Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Level 2 Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. Level 3 Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. The Company’s financial instruments consist principally of cash, accounts payable and accrued liabilities, amounts due to related parties, and convertible debentures. Pursuant to ASC 820 and 825, the fair value of our cash and cash equivalents is determined based on “Level 1” inputs, which consist of quoted prices in active markets for identical assets. We believe that the recorded values of all of our other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations. The Company’s operations are in Canada, which results in exposure to market risks from changes in foreign currency rates. The financial risk is the risk to the Company’s operations that arise from fluctuations in foreign exchange rates and the degree of volatility of these rates. Currently, the Company does not use derivative instruments to reduce its exposure to foreign currency risk. The following table presents assets and liabilities that are measured and recognized at fair value as of December 31, 2015, 2014, and 2013 on a recurring basis: December 31, 2013 Description Level 1 $ Level 2 $ Level 3 $ Total Gains and (Losses) $ Derivative liability — (286,669 ) — (168,930 ) Total — (286,669 ) — (168,930 ) December 31, 2014 Description Level 1 $ Level 2 $ Level 3 $ Total Gains and (Losses) $ Derivative liability — (237,061 ) — (82,138 ) Total — (237,061 ) — (82,138 ) December 31, 2015 Description Level 1 $ Level 2 $ Level 3 $ Total Gains and (Losses) $ Derivative liability — (292,320 ) — (202,193 ) Total — (292,320 ) — (202,193 )
Foreign Currency Translation	n) Foreign Currency Translation The Company’s functional and reporting currency is the United States dollar. Monetary assets and liabilities denominated in foreign currencies are translated in accordance with ASC 830 Foreign Currency Translation Matters,
Recent Accounting Pronouncements	o) Recent Accounting Pronouncements The Company has implemented all new accounting pronouncements that are in effect. These pronouncements did not have any material impact on the financial statements unless otherwise disclosed, and the Company does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

Summary of Significant Accoun20

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2015
Accounting Policies [Abstract]
Assets and liabilities measure and recognized at fair value on a recurring basis	December 31, 2013 Description Level 1 $ Level 2 $ Level 3 $ Total Gains and (Losses) $ Derivative liability — (286,669 ) — (168,930 ) Total — (286,669 ) — (168,930 ) December 31, 2014 Description Level 1 $ Level 2 $ Level 3 $ Total Gains and (Losses) $ Derivative liability — (237,061 ) — (82,138 ) Total — (237,061 ) — (82,138 ) December 31, 2015 Description Level 1 $ Level 2 $ Level 3 $ Total Gains and (Losses) $ Derivative liability — (292,320 ) — (202,193 ) Total — (292,320 ) — (202,193 )

Property and Equipment (Tables)

Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2015
Property, Plant and Equipment [Abstract]
Property and equipment	Net Book Value Cost $ Accumulated Depreciation $ December 31, 2015 $ December 31, 2014 $ December 31, 2013 $ Equipment 47,861 45,599 2,262 5,885 9,914

Derivative Liability (Tables)

Derivative Liability (Tables)	12 Months Ended
	Dec. 31, 2015
Notes to Financial Statements
Summary of activity of derivative liability	$ Balance at December 31, 2012 26,627 Debt discount 124,902 Derivative due to mark to market adjustment 135,150 Balance at December 31, 2013 286,679 Derivative loss due to new issuances 122,265 Debt discount 261,000 Reclass to share capital (355,825 ) Derivative due to mark to market adjustment (77,058 ) Balance at December 31, 2014 237,061 Derivative loss due to new issuances 91,358 Debt discount 137,374 Reclass to share capital (282,806 ) Derivative due to mark to market adjustment 109,333 Balance at December 31, 2015 292,320

Share Purchase Warrants (Tables

Share Purchase Warrants (Tables)	12 Months Ended
	Dec. 31, 2015
Equity [Abstract]
Continuity schedule for share purchase warrants	Exercise Price Number of Warrants $ Balance – December 31, 2012 18,500,000 0.10 Expired (2,500,000) 0.10 Balance – December 31, 2013 16,000,000 Expired (16,000,000) Balance – December 31, 2014 and 2015 — —

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2015
Income Tax Disclosure [Abstract]
Effective income tax rate reconciliation	2015 2014 2013 $ $ $ Loss Before Taxes (716,943 ) (808,710 ) (523,784 ) Statutory rate 34 % 34 % 34 % Computed expected tax recovery (243,761 ) (274,961 ) (178,087 ) Non-deductible expenses 119,469 123,694 95,886 Change in valuation allowance 124,292 151,267 82,201 Income tax expense — — —
Components of net deferred tax asset and valuation allowance	2015 2014 2013 $ $ $ Deferred tax asset Cumulative net operating losses 3,352,372 3,228,080 3,076,813 Less valuation allowance (3,352,372 ) (3,228,080 ) (3,076,813 ) Net deferred tax asset — — —
Schedule and expiration date of operating losses incurred	Expiration Net Date of Loss Operating Period Incurred $ Losses December 31, 2006 159,600 2026 December 31, 2007 2,310,000 2027 December 31, 2008 2,638,800 2028 December 31, 2009 1,665,000 2029 December 31, 2010 944,400 2030 December 31, 2011 631,600 2031 December 31, 2012 391,900 2032 December 31, 2013 252,000 2033 December 31, 2014 444,900 2034 December 31, 2015 365,600 2035 9,803,800

Restatement (Tables)

Restatement (Tables)	12 Months Ended
	Dec. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Restatement	Consolidated Balance Sheet As at December 31, 2014 As Reported $ Adjustment $ As Restated $ LIABILITIES AND STOCKHOLDERS’ DEFICIT Current liabilities Convertible debentures, net of unamortized discount 16,098 36,957 53,055 Total liabilities 267,757 36,957 304,714 Stockholders’ Deficit Common stock 18,734,351 141,477 18,875,828 Accumulated deficit (24,004,261 ) (178,434 ) (24,182,695 ) Total stockholders’ deficit (254,068 ) (36,957 ) (291,025 ) Total liabilities and stockholders’ deficit 13,689 — 13,689 Consolidated Statement of Operations Year Ended December 31, 2014 As Reported $ Adjustment $ As Restated $ Operating loss (417,491 ) (65,000 ) (482,491 ) Other income (expense) Gain (loss) on conversion of debt (7,130 ) 7,130 — Gain on forgiveness of debt — 65,000 65,000 Loss on change in fair value of derivative liabilities (45,207 ) (36,931 ) (82,138 ) Accretion and interest expense (242,259 ) (66,822 ) (309,081 ) Total other income (expense) (294,596 ) (31,623 ) (326,219 ) Net loss (712,087 ) (96,623 ) (808,710 ) Year Ended December 31, 2013 As Reported $ Adjustment $ As Restated $ Other income (expense) Accretion and interest expense (113,826 ) (13,705 ) (127,531 ) Loss on change in fair value of derivative liabilities (100,824 ) (68,106 ) (168,930 ) Total other income (expense) (214,650 ) (81,811 ) (296,461 ) Net loss (441,973 ) (81,811 ) (523,784 ) Consolidated Statements of Stockholders' Deficit As at December 31, 2014 As Reported $ Adjustment $ As Restated $ Common stock 18,734,351 141,477 18,875,828 Accumulated deficit (24,004,261 ) (178,434 ) (24,182,695 ) Total (254,068 ) (36,957 ) (291,025 ) As at December 31, 2013 As Reported $ Adjustment $ As Restated $ Common stock 17,956,296 47,485 18,003,782 Accumulated deficit (23,292,174 ) (81,811 ) (23,373,985 ) Total (320,035 ) (34,326 ) (354,361 ) Consolidated Statement of Cash Flows Year Ended December 31, 2014 As Reported $ Adjustment $ As Restated $ Operating Activities Net loss (712,087 ) (96,623 ) (808,710 ) Adjustments to reconcile net loss to net cash used in operating activities: Accretion expense 229,717 57,922 287,639 Gain (loss) on conversion of debt 7,130 (7,130 ) — Loss on change in fair value of derivative liabilities 45,207 36,931 82,138 Changes in operating assets and liabilities: Deferred financing costs 2,637 24,899 27,536 Accounts payable and accrued liabilities 5,684 1 5,685 Net cash used in operating activities (394,493 ) 16,000 (378,493 ) Financing Activities Proceeds from issuance of convertible debt 261,000 (16,000 ) 245,000 Net cash provided by financing activities 354,296 (16,000 ) 338,296 Year Ended December 31, 2013 As Reported $ Adjustment $ As Restated $ Operating Activities Net loss (441,973 ) (81,811 ) (523,784 ) Adjustments to reconcile net loss to net cash used in operating activities: Accretion expense 113,826 13,705 127,531 Loss on change in fair value of derivative liabilities 100,824 68,106 168,930

Nature of Operations and Cont26

Nature of Operations and Continuance of Business (Details Narrative) - USD ($)	1 Months Ended	12 Months Ended
	Dec. 04, 2006	Dec. 31, 2001	Dec. 31, 2015
Working capital deficit			$ (273,575)
Accumulated deficit			$ (24,899,638)
Common shares of VCL Communicatinos Corp acquired
Interest acquired		100.00%
Tombstone, Arizona mineral claims acquired
Interest acquired	100.00%
Cash paid for acquisition of mineral claims	$ 100,000
Shares issued for acquisition of mineral claims	8,000,000

Summary of Significant Accoun27

Summary of Significant Accounting Policies - Assets and liabilities measured and recognized at fair value on a recurring basis (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Derivative liability	$ (202,193)	$ (82,138)	$ (168,930)
Total	(202,193)	(82,138)	(168,930)
Level 1
Derivative liability
Total
Level 2
Derivative liability	(292,320)	(237,061)	(286,669)
Total	(292,320)	(237,061)	(286,669)
Level 3
Derivative liability
Total

Summary of Significant Accoun28

Summary of Significant Accounting Policies (Details Narrative) - shares	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Accounting Policies [Abstract]
Potentially anti-dilutive shares excluded from computation of earnings per share	23,869,458	14,574,456

Property and Equipment - Proper

Property and Equipment - Property and equipment (Details) - Equipment - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Cost	$ 47,861
Accumulated amortization	45,599
Net book value	$ 2,262	$ 5,885	$ 9,914

Property and Equipment (Details

Property and Equipment (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Equipment
Depreciation expense	$ 3,623	$ 4,029	$ 5,221

Convertible Debentures (Details

Convertible Debentures (Details Narrative) - USD ($)	1 Months Ended																12 Months Ended
	Sep. 30, 2015	Aug. 31, 2015	Jul. 31, 2015	Jan. 31, 2015	Oct. 31, 2014	Jul. 31, 2014	Jun. 30, 2014	May 31, 2014	Mar. 31, 2014	Jan. 31, 2014	Dec. 31, 2013	Oct. 31, 2013	Aug. 31, 2013	Jun. 30, 2013	Apr. 30, 2013	Feb. 28, 2013	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
A
Convertible debt issued													$ 32,500			$ 37,500
Interest per annum													8.00%			8.00%
Maturity date																Nov. 15, 2013
Conversion rate																58.00%
Deferred financing costs incurred													$ 2,500
Financing costs paid																			$ 2,500
Discount to note payable													32,500			$ 28,810
Carrying value of convertible note that will be accreted over term													$ 32,500			$ 37,500
Conversion of note, shares issued																			2,349,367
Conversion of note, amount																			$ 37,500
Conversion of note, accrued interest																			1,500
Accretion expense recorded																			28,810
B
Convertible debt issued												$ 32,500			$ 32,500
Interest per annum												8.00%			8.00%
Maturity date															Jan. 15, 2014
Conversion rate															58.00%
Deferred financing costs incurred												$ 2,500
Financing costs paid																			$ 2,500
Discount to note payable												32,500			$ 24,979
Carrying value of convertible note that will be accreted over term												32,500			$ 32,500
Conversion of note, shares issued																			1,716,573
Conversion of note, amount																			$ 32,500
Conversion of note, accrued interest																			1,300
Accretion expense recorded																			24,979
C
Convertible debt issued												$ 32,500		$ 32,500
Interest per annum												8.00%		8.00%
Maturity date														Mar. 5, 2014
Conversion rate														58.00%
Deferred financing costs incurred												$ 2,500
Financing costs paid																			$ 2,500
Discount to note payable												32,500		$ 24,953
Carrying value of convertible note that will be accreted over term												$ 32,500		$ 32,500
Conversion of note, shares issued																			2,312,268
Conversion of note, amount																			$ 32,500
Conversion of note, accrued interest																			1,300
Accretion expense recorded																			24,953
D
Maturity date													May 5, 2014
Conversion rate													58.00%
Amortization of deferred financing costs																		$ 1,103	1,397
Conversion of note, shares issued																		1,306,199
Conversion of note, amount																		$ 32,500
Conversion of note, accrued interest																		1,300
Accretion expense recorded																		14,445	18,055
E
Convertible debt issued										$ 37,500
Interest per annum										8.00%
Maturity date												Jul. 5, 2014
Conversion rate												58.00%
Deferred financing costs incurred										$ 2,500
Amortization of deferred financing costs																		$ 1,664	836
Discount to note payable										37,500
Carrying value of convertible note that will be accreted over term										$ 37,500
Conversion of note, shares issued																		1,687,097
Conversion of note, amount																		$ 32,500
Conversion of note, accrued interest																		1,300
Accretion expense recorded																		21,667	10,833
F
Convertible debt issued									$ 32,500
Interest per annum									8.00%
Maturity date												Aug. 4, 2014
Conversion rate												58.00%
Deferred financing costs incurred									$ 2,500
Amortization of deferred financing costs																		$ 1,939	561
Discount to note payable									32,500
Carrying value of convertible note that will be accreted over term									$ 32,500
Conversion of note, shares issued																		1,442,781
Conversion of note, amount																		$ 32,500
Conversion of note, accrued interest																		1,300
Accretion expense recorded																		25,278	7,222
G
Convertible debt issued								$ 42,500
Interest per annum								8.00%
Maturity date											Sep. 19, 2014
Conversion rate											58.00%
Deferred financing costs incurred								$ 2,500
Amortization of deferred financing costs																		$ 2,372	128
Discount to note payable								42,500
Carrying value of convertible note that will be accreted over term								$ 42,500
Conversion of note, shares issued																		1,383,394
Conversion of note, amount																		$ 32,500
Conversion of note, accrued interest																		1,300
Accretion expense recorded											$ 1,266							30,694	$ 1,806
H
Convertible debt issued							$ 68,000
Interest per annum							8.00%
Maturity date										Oct. 14, 2014
Conversion rate										58.00%
Deferred financing costs incurred							$ 3,000
Amortization of deferred financing costs																		$ 2,500
Discount to note payable							68,000
Carrying value of convertible note that will be accreted over term							$ 68,000
Conversion of note, shares issued																		1,906,938
Conversion of note, amount																		$ 37,500
Conversion of note, accrued interest																		1,500
Accretion expense recorded																		37,500
I
Convertible debt issued						$ 42,500
Interest per annum						8.00%
Maturity date									Dec. 26, 2014
Conversion rate									58.00%
Deferred financing costs incurred						$ 2,500
Amortization of deferred financing costs																		$ 2,500
Discount to note payable						42,500
Carrying value of convertible note that will be accreted over term						$ 42,500
Conversion of note, shares issued																		3,318,215
Conversion of note, amount																		$ 32,500
Conversion of note, accrued interest																		1,700
Accretion expense recorded																		32,500
J
Convertible debt issued					$ 38,000
Interest per annum					8.00%
Maturity date								Feb. 16, 2015
Conversion rate								58.00%
Deferred financing costs incurred					$ 3,000
Amortization of deferred financing costs																	423	$ 2,077
Discount to note payable					38,000
Carrying value of convertible note that will be accreted over term					$ 38,000
Conversion of note, shares issued																		3,980,077
Conversion of note, amount																		$ 42,500
Conversion of note, accrued interest																		1,300
Accretion expense recorded																		42,500
K
Maturity date							Mar. 18, 2015
Conversion rate							58.00%
Amortization of deferred financing costs																	$ 840	$ 2,160
Conversion of note, shares issued																	5,735,211	3,402,974
Conversion of note, amount																	$ 38,000	$ 30,000
Conversion of note, accrued interest																	2,720
Accretion expense recorded																	17,000	51,000
L
Convertible debt issued			$ 46,000
Interest per annum			10.00%
Maturity date						Apr. 11, 2015
Conversion rate						58.00%
Deferred financing costs incurred			$ 1,500
Amortization of deferred financing costs																	$ 915	1,585
Discount to note payable			6,265
Carrying value of convertible note that will be accreted over term			46,000
Conversion of note, shares issued																	6,075,118
Conversion of note, amount																	$ 42,500
Conversion of note, accrued interest																	1,700
Accretion expense recorded																	18,889	23,611
M
Convertible debt issued		$ 250,000
Interest per annum		12.00%
Maturity date					Jul. 28, 2015
Conversion rate					58.00%
Amortization of deferred financing costs																	$ 2,264	736
Conversion of note, shares issued																	4,947,683
Conversion of note, amount																	$ 28,830
Conversion of note, accrued interest																	1,520
Accretion expense recorded																	29,556	$ 8,444
Repayment of note with cash																	13,780
Additional interest expense as result of default on loan																	4,610
N
Convertible debt issued	$ 33,500			$ 43,000
Proceeds received				41,500
Original issue discount				$ 1,500
Interest per annum	10.00%			10.00%
Maturity date				Jan. 5, 2016
Conversion rate				58.00%
Deferred financing costs incurred	$ 1,000			$ 1,500
Amortization of deferred financing costs																	$ 1,484
Discount to note payable	4,775			40,000
Carrying value of convertible note that will be accreted over term	33,500			$ 43,000
Conversion of note, shares issued																	7,186,111
Conversion of note, amount																	$ 43,000
Conversion of note, accrued interest																	2,704
Accretion expense recorded																	40,000
O
Proceeds received			42,500
Original issue discount			$ 35,000
Maturity date			Jul. 7, 2016
Conversion rate			58.00%
Amortization of deferred financing costs																	730
Accretion expense recorded																	3,133
P
Conversion rate		60.00%
P - First Tranche
Proceeds received																	50,000
Original issue discount																	5,556
Accretion expense recorded																	23,148
P - Second Tranche
Proceeds received																	25,000
Original issue discount																	2,778
Accretion expense recorded																	1,157
Q
Proceeds received	31,000
Original issue discount	$ 2,500
Maturity date	Sep. 28, 2016
Conversion rate	58.00%
Amortization of deferred financing costs																	260
Accretion expense recorded																	$ 1,194

Derivative Liability - Summary

Derivative Liability - Summary of activity of derivative liability (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Notes to Financial Statements
Balance	$ 292,320	$ 237,061	$ 286,679	$ 26,627
Derivative loss due to new issuances	91,358	122,265
Debt discount	137,374	261,000	124,902
Reclass to share capital	(282,806)	(355,825)
Derivative due to mark to market adjustment	$ 109,333	$ (77,058)	$ 135,150

Derivative Liability (Details N

Derivative Liability (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Derivative liability	$ 292,320	$ 237,061	$ 286,679
Expected volatility, minimum	182.00%	194.00%	270.00%
Expected volatility, maximum	304.00%	316.00%	316.00%
Risk-free interest rate, interest	0.01%	0.01%
Risk-free interest rate, maximum	1.06%	0.15%	1.00%
Expected dividend yield	0.00%	0.00%	0.00%
Expected life, minimum	29 days	2 months 12 days	6 months
Expected life, maximum	2 years	9 months 7 days	3 years
Warrants issued
Derivative liability
Gain/loss on fair value of derivatives		127,451
Convertible debentures issued
Derivative liability	292,320	237,061
Gain/loss on fair value of derivatives	$ (202,193)	$ (209,589)

Common Shares and Common Stoc34

Common Shares and Common Stock Subscribed (Details Narrative) - USD ($)	Mar. 20, 2015	Feb. 02, 2015	May 20, 2014	Aug. 23, 2013	Jun. 20, 2013	Jan. 07, 2013	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 28, 2015	Dec. 21, 2015	Aug. 31, 2011
Proceeds received from issuance of common stock subscription, amount										$ 100,000	$ 50,000	$ 50,000
Common shares issued from subscriptions										10,000,000	5,000,000
Price per share of common shares issued										$ 0.01	$ .01
Share issuance costs incurred										$ 10,000
Common Shares
Shares issued for cash, shares	5,000,000	10,000,000	69,000,000		6,500,000		15,000,000	69,000,000	6,500,000
Shares issued for cash, amount	$ 50,000	$ 100,000	$ 100,000		$ 65,000		$ 150,000	$ 100,000	$ 65,000
Shares issued for cash, price per share	$ 0.01	$ 0.01
Shares issued for services, shares		500,000				675,000	500,000	2,000,000
Shares issued for services, amount		$ 5,900				$ 11,475	$ 5,900	$ 88,190
Issuance of common shares for settlement of related party payable, shares					5,200,000				5,200,000
Issuance of common shares for settlement of related party payable, amount					$ 52,000				$ 52,000
Shares issued upon conversion of convertible notes payable and accrued interest, shares				6,378,208			23,944,123	18,427,675	6,378,209
Shares issued upon conversion of convertible notes payable and accrued interest, amount				$ 228,727			$ 442,282	$ 683,856	$ 228,727

Contingencies (Details Narrativ

Contingencies (Details Narrative) - USD ($)	Nov. 20, 2014	May 13, 2014	Dec. 14, 2013	Jan. 02, 2015	Jun. 13, 2014	Oct. 31, 2014	Aug. 30, 2014	Dec. 31, 2015
Single payment not yet received, recorded as an allowance to offset amount receivable, along with corresponding loss on settlement of debt								$ 400,000
Agreement
EuroGas AG shares to be acquired			240,000,000
Interests to be acquired			26.00%
Cash to be received			$ 5,000,000
Company shares to be issued in exchange			348,000,000
Second Amendment
EuroGas AG shares to be acquired					240,000,000
Cash to be received		$ 100,000			$ 400,000	$ 4,000,000	$ 500,000
Company shares to be issued in exchange		69,000,000			279,000,000
Extension Agreement
Cash to be received	$ 400,000			$ 4,500,000

Share Purchase Warrants - Conti

Share Purchase Warrants - Continuity schedule for share purchase warrants (Details) - Share purchase warrants - $ / shares	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2015	Dec. 31, 2012
Balance of warrants		1,600,000		18,500,000
Warrant exercise price		$ .10		$ .10
Warrants expired	(16,000,000)	(2,500,000)
Expired warrants exercise price	$ .10	$ .10

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Related Party Transactions [Abstract]
Amounts owed for management fees	$ 4,408	$ 3,950	$ 10,654
Fees incurred	$ 135,000	$ 120,000	$ 120,000

Income Taxes - Effective income

Income Taxes - Effective income tax rate reconciliation (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Income Tax Disclosure [Abstract]
Loss Before Taxes	$ (716,943)	$ (808,710)	$ (523,784)
Statutory rate	34.00%	34.00%	34.00%
Computed expected tax recovery	$ (243,761)	$ (274,961)	$ (178,087)
Non-deductible expenses	119,469	123,694	95,886
Change in valuation allowance	124,292	151,267	82,201
Reported income taxes

Income Taxes - Components of ne

Income Taxes - Components of net deferred tax asset and valuation allowance (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Deferred tax assets
Cumulative net operating losses	$ 3,352,372	$ 3,228,080	$ 3,076,813
Less valuation allowance	(3,352,372)	(3,228,080)	(3,076,813)
Net deferred tax asset

Income Taxes - Schedule and exp

Income Taxes - Schedule and expiration date of operating losses incurred (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2008	Dec. 31, 2007	Dec. 31, 2006
Period Incurred
Net loss	$ 365,600	$ 444,900	$ 252,000	$ 391,900	$ 631,600	$ 944,400	$ 1,665,000	$ 2,638,800	$ 2,310,000	$ 159,600
Expiration date of operating losses	Dec. 31, 2035	Dec. 31, 2034	Dec. 31, 2033	Dec. 31, 2032	Dec. 31, 2031	Dec. 31, 2030	Dec. 31, 2029	Dec. 31, 2028	Dec. 31, 2027	Dec. 31, 2026
Total
Net loss	$ 9,803,800

Income Taxes (Details Narrative

Income Taxes (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2035
Income Tax Disclosure [Abstract]
Net operating loss carryforwards				$ 9,803,800
Change in valuation allowance established against deferred tax assets	$ 124,292	$ 151,267	$ 82,201

Restatement - Restatement of Co

Restatement - Restatement of Consolidated Balance Sheet (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Stockholders' Deficit
Accumulated deficit	$ (24,899,638)
As Reported
Current liabilities
Convertible debenture, net of unamortized discount		$ 16,098
Total liabilities		267,757
Stockholders' Deficit
Common stock		18,734,351	$ 17,956,296
Accumulated deficit		(24,004,261)	(23,292,174)
Total stockholders' deficit		(254,068)	(320,035)
Total liabilities and stockholders' deficit		13,689
Adjustment
Current liabilities
Convertible debenture, net of unamortized discount		36,957
Total liabilities		36,957
Stockholders' Deficit
Common stock		141,477	47,485
Accumulated deficit		(178,434)	(81,811)
Total stockholders' deficit		(36,957)	(34,326)
Total liabilities and stockholders' deficit
As Restated
Current liabilities
Convertible debenture, net of unamortized discount		53,055
Total liabilities		304,714
Stockholders' Deficit
Common stock		18,875,828	18,003,782
Accumulated deficit		(24,182,695)	(23,373,985)
Total stockholders' deficit		(291,025)	$ (354,361)
Total liabilities and stockholders' deficit		$ 13,689

Restatement - Restatement of 43

Restatement - Restatement of Consolidated Statement of Operations (Details) - USD ($)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
As Reported
Operating loss	$ (417,491)
Other income (expense)
Gain (loss) on conversion of debt	(7,130)
Gain on forgiveness of debt
Loss on change in fair value of derivative liabilities	(45,207)	$ (100,824)
Accretion and interest expense	(242,259)	(113,826)
Total other income (expense)	(294,596)	(214,650)
Net loss	(712,087)	(441,973)
Adjustment
Operating loss	(65,000)
Other income (expense)
Gain (loss) on conversion of debt	7,130
Gain on forgiveness of debt	65,000
Loss on change in fair value of derivative liabilities	(36,931)	(68,106)
Accretion and interest expense	(66,822)	(13,705)
Total other income (expense)	(31,623)	(81,811)
Net loss	(96,623)	(81,811)
As Restated
Operating loss	(482,491)
Other income (expense)
Gain (loss) on conversion of debt
Gain on forgiveness of debt	65,000
Loss on change in fair value of derivative liabilities	(82,138)	(168,930)
Accretion and interest expense	(309,081)	(127,531)
Total other income (expense)	(326,219)	(296,461)
Net loss	$ (808,710)	$ (523,784)

Restatement - Restatement of 44

Restatement - Restatement of Consolidated Statements of Stockholders' Deficit (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Accumulated deficit	$ (24,899,638)
As Reported
Common stock		$ 18,734,351	$ 17,956,296
Accumulated deficit		(24,004,261)	(23,292,174)
Total stockholders' deficit		(254,068)	(320,035)
Adjustment
Common stock		141,477	47,485
Accumulated deficit		(178,434)	(81,811)
Total stockholders' deficit		(36,957)	(34,326)
As Restated
Common stock		18,875,828	18,003,782
Accumulated deficit		(24,182,695)	(23,373,985)
Total stockholders' deficit		$ (291,025)	$ (354,361)

Restatement - Restatement of 45

Restatement - Restatement of Consolidated Statement of Cash Flows (Details) - USD ($)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
As Reported
Operating Activities
Net loss	$ (712,087)	$ (441,973)
Adjustments to reconcile net loss to net cash used in operating activities:
Accretion expense	229,717	113,826
Gain (loss) on conversion of debt	7,130
Loss on change in fair value of derivative liabilities	45,207	100,824
Changes in operating assets and liabilities:
Deferred financing costs	2,637
Accounts payable and accrued liabilities	5,684
Net cash used in operating activities	(394,493)
Financing Activities
Proceeds from issuance of convertible debt	261,000
Net cash provided by financing activities	354,296
Adjustment
Operating Activities
Net loss	(96,623)	(81,811)
Adjustments to reconcile net loss to net cash used in operating activities:
Accretion expense	57,922	13,705
Gain (loss) on conversion of debt	(7,130)
Loss on change in fair value of derivative liabilities	36,931	68,106
Changes in operating assets and liabilities:
Deferred financing costs	24,899
Accounts payable and accrued liabilities	1
Net cash used in operating activities	16,000
Financing Activities
Proceeds from issuance of convertible debt	(16,000)
Net cash provided by financing activities	(16,000)
As Restated
Operating Activities
Net loss	(808,710)	(523,784)
Adjustments to reconcile net loss to net cash used in operating activities:
Accretion expense	287,639	127,531
Gain (loss) on conversion of debt
Loss on change in fair value of derivative liabilities	82,138	$ 168,930
Changes in operating assets and liabilities:
Deferred financing costs	27,536
Accounts payable and accrued liabilities	5,685
Net cash used in operating activities	(378,493)
Financing Activities
Proceeds from issuance of convertible debt	245,000
Net cash provided by financing activities	$ 338,296

Restatement (Details Narrative)

Restatement (Details Narrative)	12 Months Ended
	Dec. 31, 2014USD ($)
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Increase to net loss as result of restatement	$ (96,623)

Subsequent Events (Details Narr

Subsequent Events (Details Narrative) - USD ($)	Apr. 26, 2016	Apr. 05, 2016	Mar. 10, 2016	Mar. 03, 2016	Mar. 02, 2016	Feb. 25, 2016	Feb. 19, 2016	Feb. 12, 2016	Jan. 15, 2016	Jan. 11, 2016	Feb. 04, 2016	Dec. 28, 2015	Dec. 21, 2015	Aug. 31, 2011
Proceeds received from issuance of common stock subscription, amount												$ 100,000	$ 50,000	$ 50,000
Common shares issued from subscriptions												10,000,000	5,000,000
Price per share of common shares issued												$ 0.01	$ .01
Subsequent events
Shares issued for cash, shares										15,000,000
Shares issued for cash, amount										$ 150,000
Shares issued for cash, price per share										$ 0.01
Shares issued upon conversion of convertible notes payable, shares	3,029,556	2,500,000	1,800,000	1,400,000	2,686,968	1,100,000	2,298,850	1,000,000	2,068,965
Shares issued upon conversion of convertible notes payable, amount	$ 10,000	$ 10,650	$ 8,316	$ 6,636	$ 12,000	$ 5,544	$ 12,000	$ 5,300	$ 12,000
Shares issued upon conversion of convertible notes payable, accrued interest amount	$ 2,300
Proceeds received from issuance of common stock subscription, amount											$ 50,000
Common shares issued from subscriptions											5,000,000
Price per share of common shares issued											$ 0.01